Intravenous immunoglobulin therapy in adult patients with idiopathic chronic cardiomyopathy and cardiac parvovirus B19 persistence: a prospective, double‐blind, randomized, placebo‐controlled clinical trial

AIMS: Previous uncontrolled studies suggested a possible benefit of intravenous immunoglobulin (IVIg) in parvovirus B19 (B19V)‐related dilated cardiomyopathy (DCM). This randomized, double‐blind, placebo‐controlled, single‐centre trial investigated the benefits of IVIg beyond conventional therapy in...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Eur J Heart Fail
Main Authors: Hazebroek, Mark R., Henkens, Michiel T.H.M., Raafs, Anne G., Verdonschot, Job A.J., Merken, Jort J., Dennert, Robert M., Eurlings, Casper, Abdul Hamid, Myrurgia A., Wolffs, Petra F.G., Winkens, Bjorn, Brunner‐La Rocca, Hans‐Peter, Knackstedt, Christian, van Paassen, Pieter, van Empel, Vanessa P.M., Heymans, Stephane R.B.
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons, Ltd 2021
Teme:
Focus on Myocarditis, Cardiomyopathy and Amyloidosis
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8048650/
https://ncbi.nlm.nih.gov/pubmed/33347677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ejhf.2082
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki